Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Kyocera ( (JP:6971) ) has provided an announcement.
Kyocera Corporation announced a strategic move to split its medical business into a newly formed subsidiary, Kyocera Medical Corporation, through an absorption-type company split effective October 1, 2025. This restructuring aims to enhance the company’s ability to meet the evolving demands of the medical device industry, improve responsiveness to regulatory changes, and accelerate business growth, ultimately contributing to the global medical market’s development.
The most recent analyst rating on (JP:6971) stock is a Buy with a Yen2000.00 price target. To see the full list of analyst forecasts on Kyocera stock, see the JP:6971 Stock Forecast page.
More about Kyocera
Kyocera Corporation operates in the medical device industry, focusing on the development, manufacturing, and sale of artificial joints and dental implants. The company aims to address the increasing international requirements for safety and quality in the medical device sector.
Average Trading Volume: 4,748,106
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen2415.1B
See more insights into 6971 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue